Low-molecular-weight heparin for thrombophilia in pregnant women (Q33332833)

25 July 2017

title

Low-molecular-weight heparin for thrombophilia in pregnant women (English)

1 reference

25 July 2017

1 reference

1 reference

1 reference

1 reference

J Bar

1

1 reference

25 July 2017

B Cohen-Sacher

2

1 reference

25 July 2017

M Hod

3

1 reference

25 July 2017

D Blickstein

4

1 reference

25 July 2017

J Lahav

5

1 reference

25 July 2017

P Merlob

6

1 reference

25 July 2017

publication date

1 June 2000

1 reference

International Journal of Gynecology and Obstetrics

25 July 2017

published in

1 reference

25 July 2017

volume

69

1 reference

25 July 2017

issue

3

1 reference

25 July 2017

page(s)

209-213

1 reference

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900202-2

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900202-2

Low-molecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900202-2

Increased fetal loss in women with heritable thrombophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900202-2

Increased frequency of genetic thrombophilia in women with complications of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900202-2

Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900202-2

Underlying disorders associated with severe early-onset preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900202-2

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900202-2

Placental transport of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900202-2

Bone density studies in pregnant women receiving heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900202-2

Placental transfer of glycosaminoglycans in the human perfused placental cotyledon model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900202-2

Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900202-2

Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900202-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0020-7292(00)00202-2

1 reference

25 July 2017

1 reference